Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation

Journal of Cellular Physiology

Volumn 223, Issue 3, 2010, Pages 623-629

  Zou, Li ^a   Ding, Zhijie ^a   Roy, Partha ^a,b  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROFILIN; PROFILIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; GENE OVEREXPRESSION; GENE SILENCING; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; UPREGULATION; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROFILINS; PROTEIN STABILITY; UP-REGULATION;

EID: 77951247289     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22058     Document Type: Article

References (36)

1. Balasubramanian MK, Hirani BR, Burke JD, Gould KL. 1994. The Schizosaccharomyces pombe cdc3+ gene encodes a profilin essential for cytokinesis. J Cell Biol 125:1289-1301. (Pubitemid 24189533)
2. Blain SW, Massague J. 2002. Breast cancer banishes p27 from nucleus. Nat Med 8:1076-1078. (Pubitemid 35175956)
3. Bottcher RT, Wiesner S, Braun A, Wimmer R, Berna A, Elad N, Medalia O, Pfeifer A, Aszodi A, Costell M, Fassler R. 2009. Profilin 1 is required for abscission during late cytokinesis of chondrocytes. EMBO J 28:1157-1169.
4. Chu IM, Hengst L, Slingerland JM. 2008. The Cdk inhibitor p27 in human cancer: Prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 8:253-267. (Pubitemid 351430863)
5. Das T, Bae YH, Wells A, Roy P. 2009. Profilin-1 overexpression upregulates PTEN and suppresses AKT activation in breast cancer cells. J Cell Physiol 218:436-443.
6. Ding Z, Lambrechts A, Parepally M, Roy P. 2006. Silencing profilin-1 inhibits endothelial cell proliferation, migration and cord morphogenesis. J Cell Sci 119:4127-4137. (Pubitemid 44650884)
7. Frattini M, Saletti P, Romagnani E, Martin V, Molinari F, Ghisletta M, Camponovo A, Etienne LL, Cavalli F, Mazzucchelli L. 2007. PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients. Br J Cancer 97:1139-1145.
8. Grimmler M, Wang Y, Mund T, Cilensek Z, Keidel EM, Waddell MB, Jakel H, Kullmann M, Kriwacki RW, Hengst L. 2007. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 128:269-280.
9. Gronborg M, Kristiansen TZ, Iwahori A, Chang R, Reddy R, Sato N, Molina H, Jensen ON, Hruban RH, Goggins MG, Maitra A, Pandey A. 2006. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 5:157-171.
10. Ishida N, Hara T, Kamura T, Yoshida M, Nakayama K, Nakayama KI. 2002. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J Biol Chem 277:14355-14358. (Pubitemid 34952496)
11. Janke J, Schluter K, Jandrig B, Theile M, Kolble K, Arnold W, Grinstein E, Schwartz A, Estevez-Schwarz L, Schlag PM, Jockusch BM, Scherneck S. 2000. Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1. J Exp Med 191:1675-1686.
12. Jiang Z, Pore N, Cerniglia GJ, Mick R, Georgescu MM, Bernhard EJ, Hahn SM, Gupta AK, Maity A. 2007. Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir. Cancer Res 67:4467-4473.
13. Jockusch BM, Murk K, Rothkegel M. 2007. The profile of profilins. Rev Physiol Biochem Pharmacol 159:131-149.
14. Kaldis P. 2007. Another piece of the p27Kip1 puzzle. Cell 128:241-244.
15. Kamura T, Hara T, Matsumoto M, Ishida N, Okumura F, Hatakeyama S, Yoshida M, Nakayama K, Nakayama KI. 2004. Cytoplasmic ubiquitin ligase KPCregulates proteolysis of p27(Kip1) at G1 phase. Nat Cell Biol 6:1229-1235.
16. le Sage C, Nagel R, Agami R. 2007. Diverse ways to control p27Kip1 function: miRNAs come into play. Cell Cycle 6:2742-2749. (Pubitemid 350277164)
17. Lee JG, Kay EP. 2008. Involvement of two distinct ubiquitin E3 ligase systems for p27 degradation in corneal endothelial cells. Invest Ophthalmol Vis Sci 49:189-196.
18. Liang J, Slingerland JM. 2003. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2:339-345.
19. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E, Slingerland JM. 2002. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8:1153-1160.
20. Migita T, Oda Y, Masuda K, Hirata A, Kuwano M, Naito S, Tsuneyoshi M. 2008. Inverse relationship between E-cadherin and p27Kip1 expression in renal cell carcinoma. Int J Oncol 33:41-47.
21. Motti ML, Califano D, Baldassarre G, Celetti A, Merolla F, Forzati F, Napolitano M, Tavernise B, Fusco A, Viglietto G. 2005. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas. Carcinogenesis 26:1021-1034.
22. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. 1994. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8:9-22. (Pubitemid 2042846)
23. Severson AF, Baillie DL, Bowerman B. 2002. A Formin Homology protein and a profilin are required for cytokinesis and Arp2/3-independent assembly of cortical microfilaments in C. elegans. Curr Biol 12:2066-2075. (Pubitemid 36021884)
24. Sherr CJ. 1994. G1 phase progression: Cycling on cue. Cell 79:551-555.
25. Sherr CJ, Roberts JM. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163.
26. St Croix B, Sheehan C, Rak JW, Florenes VA, Slingerland JM, Kerbel RS. 1998. E-Cadherindependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J Cell Biol 142:557-571. (Pubitemid 28361560)
27. Subauste MC, Nalbant P, Adamson ED, Hahn KM. 2005. Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein beta-catenin with the scaffolding protein MAGI-2. J Biol Chem 280:5676-5681. (Pubitemid 40280047)
28. Uegaki K, Kanamori Y, Kigawa J, Kawaguchi W, Kaneko R, Naniwa J, Takahashi M, Shimada M, Oishi T, Itamochi H, Terakawa N. 2006. PTEN is involved in the signal transduction pathway of contact inhibition in endometrial cells. Cell Tissue Res 323:523-528.
29. Vervoorts J, Luscher B. 2008. Post-translational regulation of the tumor suppressor p27(KIP1). Cell Mol Life Sci 65:3255-3264.
30. Witke W. 2004. The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol 14:461-469. (Pubitemid 39092704)
31. Witke W, Sutherland JD, Sharpe A, Arai M, Kwiatkowski DJ. 2001. Profilin I is essential for cell survival and cell division in early mouse development. Proc Natl Acad Sci USA 98:3832-3836. (Pubitemid 32249857)
32. Wittenmayer N, Jandrig B, Rothkegel M, Schluter K, Arnold W, Haensch W, Scherneck S, Jockusch BM. 2004. Tumor suppressor activity of profilin requires a functional actin binding site. Mol Biol Cell 15:1600-1608. (Pubitemid 38401811)
33. Wu N, Zhang W, Yang Y, Liang YL, Wang LY, Jin JW, Cai XM, Zha XL. 2006. Profilin 1 obtained by proteomic analysis in all-trans retinoic acid-treated hepatocarcinoma cell lines is involved in inhibition of cell proliferation and migration. Proteomics 6:6095-6106.
34. Yan X, Fraser M, Qiu Q, Tsang BK. 2006. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner. Gynecol Oncol 102:348-355. (Pubitemid 44063583)
35. Zou L, Jaramillo M, Whaley D, Wells A, Panchapakesa V, Das T, Roy P. 2007. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br J Cancer 97:1361-1371.
36. Zou L, Hazan R, Roy P. 2009. Profilin-1 overexpression restores adherens junctions in MDAMB- 231 breast cancer cells in R-cadherin-dependent manner. Cell Motil Cytoskeleton 66:1048-1056.